Nanobiotix S.A. 0QAV.L Stock
Nanobiotix S.A. Price Chart
Nanobiotix S.A. 0QAV.L Financial and Trading Overview
| Nanobiotix S.A. stock price | 5.43 EUR |
| Previous Close | 4.8 EUR |
| Open | 4.87 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 4.87 - 4.87 EUR |
| 52 Week Range | 1.62 - 7.04 EUR |
| Volume | 25 EUR |
| Avg. Volume | 18.65K EUR |
| Market Cap | 1.07M EUR |
| Beta (5Y Monthly) | 1.719535 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.355 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0QAV.L Valuation Measures
| Enterprise Value | 180.3M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.22310929 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 37.751 |
| Enterprise Value/EBITDA | -3.993 |
Trading Information
Nanobiotix S.A. Stock Price History
| Beta (5Y Monthly) | 1.719535 |
| 52-Week Change | 34.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.04 EUR |
| 52 Week Low | 1.62 EUR |
| 50-Day Moving Average | 3.99 EUR |
| 200-Day Moving Average | 3.79 EUR |
0QAV.L Share Statistics
| Avg. Volume (3 month) | 18.65K EUR |
| Avg. Daily Volume (10-Days) | 11.74K EUR |
| Shares Outstanding | 19.61M |
| Float | 30.51M |
| Short Ratio | N/A |
| % Held by Insiders | 3.78% |
| % Held by Institutions | 25.61% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -957.22% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.37% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 4.78M EUR |
| Revenue Per Share (ttm) | 0.14 EUR |
| Quarterly Revenue Growth (yoy) | 159.60% |
| Gross Profit (ttm) | 4.78M EUR |
| EBITDA | -45151000 EUR |
| Net Income Avi to Common (ttm) | -57041000 EUR |
| Diluted EPS (ttm) | -1.355 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.39M EUR |
| Total Cash Per Share (mrq) | 1.19 EUR |
| Total Debt (mrq) | 53.17M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.38 |
| Book Value Per Share (mrq) | -0.776 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -37104000 EUR |
| Levered Free Cash Flow (ttm) | -24736250 EUR |
Profile of Nanobiotix S.A.
| Country | United Kingdom |
| State | N/A |
| City | Paris |
| Address | 60 rue de Wattignies |
| ZIP | 75012 |
| Phone | 33 1 40 26 04 70 |
| Website | https://www.nanobiotix.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 102 |
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
Q&A For Nanobiotix S.A. Stock
What is a current 0QAV.L stock price?
Nanobiotix S.A. 0QAV.L stock price today per share is 5.43 EUR.
How to purchase Nanobiotix S.A. stock?
You can buy 0QAV.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nanobiotix S.A.?
The stock symbol or ticker of Nanobiotix S.A. is 0QAV.L.
How many shares does Nanobiotix S.A. have in circulation?
The max supply of Nanobiotix S.A. shares is 218.8K.
What is Nanobiotix S.A. Price to Earnings Ratio (PE Ratio)?
Nanobiotix S.A. PE Ratio is now.
What was Nanobiotix S.A. earnings per share over the trailing 12 months (TTM)?
Nanobiotix S.A. EPS is -1.355 EUR over the trailing 12 months.